Candani Tutuka 30th Lorne Cancer Conference 2018

Abstracts this author is presenting:

• PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation — Poster Session 2